
Matthew T. Simpson
(he/him/his)
Member / Co-chair, Private Equity Practice
+1.202.434.7436
Matt navigates his clients through complex corporate transactions including mergers and acquisitions, joint ventures, growth equity, venture capital and other minority investments, and restructurings in the U.S. and abroad.
Leveraging his broad skill set and unique background as an international negotiator, Matt serves as a strategic counselor to his clients, leading teams that structure, negotiate, and execute various transactional arrangements, with a particular focus on private equity mergers and acquisitions involving founder-run businesses. Matt also serves as outside general counsel to multiple clients, advising them on all aspects of their legal needs and taking several clients from formation to funding to IPO, and beyond.
Matt is a sought after commentator on the Private Equity industry, routinely speaking to trends and developments affecting sponsors, limited partners, and others participating in direct and indirect private equity investments.
Matt’s clients span a broad range of corporate organizations, including well-known private equity sponsors (committed funds, independent sponsors, and family offices), large multi-national corporations, and both early-stage and late-stage growth companies, across a variety of industries including technology, life sciences, healthcare, telecommunications, financial services, consumer products, energy, and manufacturing, among others.
Prior to joining Mintz, Matt worked for Torys LLP and Weil Gotshal & Manges LLP.
In addition to his corporate transactional practice, Matt is a recognized international negotiator and legal advisor. In 2010, the United Nations and African Union appointed Matt the Principal Legal Advisor to the Darfur Delegation in the Darfur Peace Negotiations. Embedded in Doha, Qatar as an official member of the Darfur delegation, Matt led a team of over two dozen international legal and policy advisors on all aspects of the peace negotiations including issues related to power and wealth sharing, the negotiation of a $2 billion development fund, the overhaul of the petroleum and natural resources sectors, and the formation of a regional government for Darfur. Since 2006, Matt has been affiliated with the Public International Law & Policy Group (PILPG) in Washington, DC where he has worked on over a dozen post-conflict legal and policy initiatives including leading the first-ever surrender to the International Criminal Court, amending the Iraqi Constitution, designing war crimes witness protection programs in Uganda, and advising on the establishment of the Republic of South Sudan. Matt currently serves in a pro bono capacity as a Senior Peace Fellow for PILPG advising on the implementation of the 2020 Sudan Peace Agreement and efforts towards a ceasefire in Ukraine.
During law school, Matt was an executive editor of the American University International Law Review and was the President and Co-Founder of the International Trade and Investment Law Society at American University.
Experience
Mergers & Acquisitions
- Charlesbank Capital Partners in its acquisition of ImageQuix Holdings, LLC, a portfolio company of ASG Group which is owned by Alpine Investors.
- Joink LLC, a DIF CIF II portfolio company owned by DIF Capital Partners, in its purchase of Illinois-based fiber optics business Computer Techniques Inc (CTI).
- Third Wave Recovery Systems (TWRX) in its acquisition of SRX, a leader in pharmaceutical rebate management services for the skilled nursing and long-term care industry.
- ProKidney LP, a leading clinical-stage cellular therapeutics company focused on chronic kidney disease, in its combination with Social Capital Suvretta Holdings Corp. III, a special purpose acquisition company (SPAC), resulting in approximately $597 million in gross cash proceeds and its subsequent listing on the Nasdaq (PROK).
- Charlesbank Capital Partners in a leveraged buyout of Solve Advisors, and the subsequent acquisition by Solve Advisors of Advantage Data Inc.
- Berenson Capital Partners in its leveraged buyout of Interactive Digital Solutions and MedSitter.
- Charlesbank Capital Partners in a leveraged buyout of Healthcare Fraud Shield, a SaaS-based software developer.
- The family office of a leading Wall Street figure in the acquisition of:
- A national youth sports platform;
- A regional paving company based in the mid-West;
- A financial services business; and
- A controlling minority position in a regional fitness platform.
- XCM Solutions, a cloud-based workflow solutions provider for professional tax and accounting firms, in its $160 million sale to Wolters Kluwer Tax & Accounting North America.
- GCM Grosvenor as a co-investor in several significant leveraged buyouts.
- Legacy.com, a Pamplona Capital-backed technology company in multiple bolt-on acquisitions.
- Motus, Inc. in an innovative leveraged buyout by Thoma Bravo, which combined Motus with Runzheimer Inc. to establish the leading vehicle management and reimbursement platform.
- Laddawn, Inc., a leading manufacturer of plastic bags and films for packing applications with over $145 million in annual net sales, to Berry Global Group, Inc. (NYSE: BERY).
- Kimberly-Clark Corporation in selling its transdermal, micro-needle drug delivery division (Sofusa) to Sorrento Therapeutics for a total of $310 million (including contingent consideration).
- A syndicate of investors in the simultaneous acquisition of three leading pharmaceutical industry firms.
- Princeton Lightwave, a developer of LiDAR technology, in its sale to Argo AI, an investment vehicle of Ford Motor Company.
- A fundless sponsor in the acquisition of an industry-leading SaaS technology company with global operations.
- KeraNetics, a Winston-Salem-based regenerative medicine business in its merger with Microchips Biotech.
- JN Phillips Auto Glass in a leveraged buyout by CenterOak Partners LLC and subsequent combination with Techna Glass, Inc. to form TruRoad Holdings, Inc., the second largest autoglass repair company in the U.S.
- A founder-run insurance data analytics firm in its acquisition by a Stone Point Capital-backed platform company.
- A leading investment advisory/broker dealer firm in the strategic acquisition of a rival’s advisors and other assets.
- A middle-market private equity fund in the acquisition of a consumer products platform company.
- A national wholesale grocery company on the acquisition of a grocery distribution company’s assets.
- AT Cross Company, a portfolio company of Clarion Capital Partners, in its acquisition of Sheaffer, BIC’s fine writing instrument business.
- A venture-backed technology company on the sale of all of its assets to a strategic investor.
- An early-stage technology company on the merger of its assets and management team with a foreign rival.
- Unizin in the spinout of its Internet 2 assets.
- A Fortune 50 global financial services firm in the acquisition of the assets of a financial services provider.
Financings
- Third Wave Recovery Systems in a growth equity investment from WindRose Health Investors, LLC.
- PleoPharma, an early stage drug development company focused on addiction treatment, in a preferred financing from multiple investors.
- Synnovation Therapeutics, an early stage drug development company, in a preferred financing.
- ArriVent Biopharma in its $150 million Series A financing.
- NexImmune, Inc., a Maryland-based immunotherapy company, in six private financing transactions as well as its February 2021 IPO, which was reported as the first upsized IPO at the top of its price range without a crossover.
- Viela Bio in its spin-out from AstraZeneca’s MedImmune division to establish a stand-alone company for early-stage inflammation and autoimmunity biologics, as well as its $250 million Series A financing, crossover financing round, and IPO.
- A small molecule drug development company in its $100 million Series A financing.
- The family office of a leading Wall Street figure in multiple investments in:
- Multiple SPAC PIPE financings; and
- A Major League Baseball team syndicate.
- The family office of a leading Wall Street figure in multiple investments in:
- A medical device marketing business;
- A craft liquor producer;
- A technology-backed restaurant platform;
- A fast casual concept restaurant platform.
- An early stage biotech venture fund in its formation, incubation of several start up companies, and ultimate fundraising.
- The family office of a leading figure in the biotech industry in over a dozen minority investments in various early-stage biotechnology issuers.
- A medical device company in its $250 million Series D private placement.
- A biotechnology issuer in a $60 million Series C private placement.
- A biotechnology issuer in a $60 million Series D private placement.
- A drug development issuer in a $25 million Series A private placement.
- A drug development issuer in a $15 million Series A private placement.
- A wastewater treatment company on an innovative project financing structure.
viewpoints
Skillful Negotiations Put Peace Within Reach
February 7, 2022 | Article
Webinar Recording: Representations & Warranties Insurance for Family Offices: How to Increase Your Odds of Winning the Bid and Decrease the Risk of the Deal
April 27, 2021 | Webinar | By Matthew T. Simpson
M&A in the COVID Era – Part III – A Dealmaker’s Guide to Post–COVID-19 Purchase and Sale Agreements
April 7, 2020 | Advisory | By Matthew T. Simpson
M&A in the COVID Era – Part I – Dealing with Distress: Strategies for Buyers of Distressed Targets in the Post–COVID-19 Era
April 2, 2020 | Advisory | By William Kannel, Matthew T. Simpson
News & Press
PE Firms Get Creative With Add-on Deal Structures
June 13, 2023
PE Turns To Add-Ons With Large LBOs Out Of Reach
May 16, 2023
Mintz Advises ArriVent Biopharma in $155M Series B Financing
March 30, 2023
Mintz Leads For Lido Advisors In Its Partnership With Colorado Financial Management
January 17, 2023
Outlook for M&A and Private Equity Deals in 2023
December 7, 2022
Outlook for M&A and Private Equity Deals in 2023
December 7, 2022
Mintz Names New Leaders In Private Equity
November 17, 2022
Mintz’s Private Equity Practice Appoints New Leadership
November 17, 2022
Mintz Leads On A Quartet of Back-To-Back Private Equity Closings
October 25, 2022
The FTC And DOJ Have Vowed To Scrutinize Private Equity Deals. Here's What It Means For Healthcare
October 21, 2022
Alumni In Excellence: Matthew Simpson
October 4, 2022
Drinks with the Deal: Mintz’s Matthew Simpson
October 1, 2021
Deal with Me: Transaction Insurance Leaders Chat with Matt and Dan
February 23, 2021
Mintz Advises NexImmune in its Upsized $126.5 Million IPO
February 17, 2021
Mintz Advises XCM Solutions in its Sale to Wolters Kluwer
September 22, 2020
DC Rising Stars: Matthew Simpson, 39
August 7, 2020
Mintz Promotes Eleven Attorneys to Member
May 10, 2019
Events & Speaking
Leveraging Transactional Insurance to Win the Bid in Mergers & Acquisitions
ACC National Capital Region Summer Series
Online Event

Recognition & Awards
- Washington D.C. Super Lawyers: Rising Star (2015 - 2021)
- The National Law Journal’s D.C. Rising Stars (2020)
Involvement
- Mintz Recommendations Committee
- Mintz Diversity Committee - Past Member
- Senior Peace Fellow (Pro Bono) – Public International Law & Policy Group
- Hobart College Alumni Association – Executive Committee Member at Large
- Former Competitive Sailor: North American, Canadian, and Provincial Champion (1993-2000)
- Former Co-Chair, Hobart and William Smith Colleges Alumni Association, Washington, DC
- Former Vice-Chairman, American Bar Association- International Trade Committee
